{"title":"Equity and Efficiency of Medical Resource Allocation in National Central Cities, China.","authors":"Minghua Zhou","doi":"10.2147/RMHP.S510508","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To analyze the equity and efficiency of medical resource allocation in national central cities in China in order to promote the development of medical resources in national central cities.</p><p><strong>Methods: </strong>Data on medical resources in 9 national central cities were extracted from 2018 to 2022, descriptive analysis, health resource density index (HRDI), and health resource agglomeration degree (HRAD) were used to evaluate equity, and data envelopment analysis (DEA) was used to evaluate efficiency.</p><p><strong>Results: </strong>The HRDI of medical resources in national central cities is higher than the Chinese average from 2018 to 2022. The HRAD for the number of beds in Shanghai, Guangzhou, and Zhengzhou is greater than 14.40, and the HRAD for registered nurses, licensed (assistant) physicians, and health technicians in Shanghai, Guangzhou, and Beijing is greater than 15.80, indicating that the medical resources in these regions are highly concentrated by geographical allocation. The HRAD/PAD for licensed (assistant) physicians, registered nurses, and health technicians in Chongqing is less than 1, indicating that there is a shortage of medical resources in these regions relative to the agglomeration population. The technical efficiency, scale efficiency and overall efficiency in Shanghai, Guangzhou, and Chongqing are all 1, and the DEA is relatively effective. In Beijing in 2018-2020, Zhengzhou in 2020, and Chengdu in 2019-2021, the overall efficiency, scale efficiency, and technical efficiency are not 1, and the DEA is relatively ineffective.</p><p><strong>Conclusion: </strong>The level of medical resource allocation in national central cities is higher than the Chinese average. The medical resources allocated in the national central cities are highly concentrated by geography. Licensed (assistant) physicians, registered nurses, and health technicians in Chongqing is insufficient relative to the agglomeration population. Except for Shanghai, Guangzhou and Chongqing, the other of the cities have a relatively inefficient allocation of medical resources.</p>","PeriodicalId":56009,"journal":{"name":"Risk Management and Healthcare Policy","volume":"18 ","pages":"1881-1893"},"PeriodicalIF":2.7000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12168990/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Risk Management and Healthcare Policy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/RMHP.S510508","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To analyze the equity and efficiency of medical resource allocation in national central cities in China in order to promote the development of medical resources in national central cities.
Methods: Data on medical resources in 9 national central cities were extracted from 2018 to 2022, descriptive analysis, health resource density index (HRDI), and health resource agglomeration degree (HRAD) were used to evaluate equity, and data envelopment analysis (DEA) was used to evaluate efficiency.
Results: The HRDI of medical resources in national central cities is higher than the Chinese average from 2018 to 2022. The HRAD for the number of beds in Shanghai, Guangzhou, and Zhengzhou is greater than 14.40, and the HRAD for registered nurses, licensed (assistant) physicians, and health technicians in Shanghai, Guangzhou, and Beijing is greater than 15.80, indicating that the medical resources in these regions are highly concentrated by geographical allocation. The HRAD/PAD for licensed (assistant) physicians, registered nurses, and health technicians in Chongqing is less than 1, indicating that there is a shortage of medical resources in these regions relative to the agglomeration population. The technical efficiency, scale efficiency and overall efficiency in Shanghai, Guangzhou, and Chongqing are all 1, and the DEA is relatively effective. In Beijing in 2018-2020, Zhengzhou in 2020, and Chengdu in 2019-2021, the overall efficiency, scale efficiency, and technical efficiency are not 1, and the DEA is relatively ineffective.
Conclusion: The level of medical resource allocation in national central cities is higher than the Chinese average. The medical resources allocated in the national central cities are highly concentrated by geography. Licensed (assistant) physicians, registered nurses, and health technicians in Chongqing is insufficient relative to the agglomeration population. Except for Shanghai, Guangzhou and Chongqing, the other of the cities have a relatively inefficient allocation of medical resources.
期刊介绍:
Risk Management and Healthcare Policy is an international, peer-reviewed, open access journal focusing on all aspects of public health, policy and preventative measures to promote good health and improve morbidity and mortality in the population. Specific topics covered in the journal include:
Public and community health
Policy and law
Preventative and predictive healthcare
Risk and hazard management
Epidemiology, detection and screening
Lifestyle and diet modification
Vaccination and disease transmission/modification programs
Health and safety and occupational health
Healthcare services provision
Health literacy and education
Advertising and promotion of health issues
Health economic evaluations and resource management
Risk Management and Healthcare Policy focuses on human interventional and observational research. The journal welcomes submitted papers covering original research, clinical and epidemiological studies, reviews and evaluations, guidelines, expert opinion and commentary, and extended reports. Case reports will only be considered if they make a valuable and original contribution to the literature. The journal does not accept study protocols, animal-based or cell line-based studies.